Active Epstein-Barr virus infection after allogeneic stem cell transplantation: Re-infection or reactivation?

Transplant Infectious Disease

Volumn 7, Issue 1, 2005, Pages 4-10

  Meijer, Ellen ^a   Spijkers, S ^b   Moschatsis, S ^b   Boland, G J ^b   Thijsen, S F T ^c   Van Loon, A M ^b   Verdonck, L F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Allogeneic stem cell transplantation; EBV strains; Epstein Barr virus; Exogenous and endogenous strains; PBMC

Indexed keywords

DNA; MEMBRANE PROTEIN;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA ISOLATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRUS INFECTION;

ADULT; ANTIGENS, VIRAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECURRENCE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VARIATION (GENETICS); VIRUS LATENCY;

EID: 22144439813     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2005.00084.x     Document Type: Article

References (27)

1. VAN ESSER JWJ, VAN DER HOLT B, MEIJER E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001: 98: 972-978.
2. MEIJER E, DEKKER AW, WEERSINK AYL, ROZENBERG-ARSKA M, VERDONCK LF. Prevention and treatment of Epstein-Barr virus associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants: a review. Br J Haematol 2002: 119: 596-607.
3. CURTIS RE, TRAVIS LB, ROWLINGS PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999: 94: 2208-2216.
4. GRATAMA JW, OOSTERVEER MAP, ZWAAN FE, et al. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci 1988: 85: 8693-8696.
5. HAQUE T, THOMAS JA, FALK KI, et al. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Virol 1996: 77: 1169-72.
6. KATZ BZ, NIEDERMAN JC, OLSON BA, MILLER G. Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts. J Infect Dis 1988: 157: 299-308.
7. CEN H, BREINIG MC, ATCHISON RW, HO M, MCKNIGHT JL. Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4. J Virol 1991: 65: 976-980.
8. KNECHT H, BACHMANN E, JOSKE DJ, et al. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 1993: 7: 580-585.
9. SCHAFER H, BERGER C, AEPINUS C, et al. Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting. Transplantation 2001: 72: 492-496.
10. BERGER C, VAN BAARLE D, KERSTEN MJ, et al. Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification. J Infect Dis 1999: 179: 240-244.
11. VAN KOOIJ B, THIJSSEN SFT, MEIJER E, et al. Sequence analysis of EBV DNA isolated from mouth washings and PBMCs of healthy individuals and blood of EBV-LPD patients. J Clin Virol 2003: 28: 85-92.
12. MEIJER E, DEKKER AW, ROZENBERG-ARSKA M, WEERSINK AJL, VERDONCK LF. Influence of cytomegalovirus-seropositivity on outcome after T cell depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors. Clin Infect Dis 2002: 35: 703-712.
13. VAN DOORNUM GJJ, GULDEMEESTER J, OSTERHAUS ADME, NIESTERS HGM. Diagnosing herpes virus infections by real-time amplification and rapid culture. J Clin Microbiol 2003: 41: 576-580.
14. VAN ESSER JWJ, NIESTERS HGM, VAN DER HOLT B, et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and pre-emptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002: 99: 4364-4369.
15. NIESTERS HG, VAN ESSER J, FRIES E, WOLTHERS KC, CORNELISSEN J, OSTERHAUS AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000: 38: 712-715.
16. HUDSON GS, FARRELL PJ, BARRELL BG. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 1985: 53: 528-535.
17. GRATAMA JW, OOSTERVEER MA, KLEIN G, ERNBERG I. EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J Virol 1990: 64: 4703-4708.
18. GRATAMA JW, OOSTERVEER MA, LEPOUTRE JM, et al. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation 1990: 49: 725-730.
19. FAULKNER GC, KRAJEWSKI AS, CRAWFORD DH. The ins and outs of EBV infection. Trends Microbiol 2000: 8: 185-189 (Review).
20. FAULKNER GC, BURROWS SR, KHANNA R, MOSS DJ, BIRD AG, CRAWFORD DH. X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol 1999: 73: 1555-1564.
21. KIEFF E, RICKINSON AB. Epstein-Barr virus and its replication. In KNIPE DM, HOWLEY PM, eds. Fields Virology. Philadelphia: Lippincott Williams & Wilkins, 2001: 2511-2627.
22. GRATAMA JW, LENNETTE ET, LONNQVIST B, et al. Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J Med Virol 1992: 37: 39-47.
23. GRATAMA JW, OOSTERVEER MA, WEIMAR W, et al. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol 1994: 75: 85-94.
24. YAO QY, TIERNEY RJ, CROOM-CARTER D, et al. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol 1996: 70: 4884-4894.
25. YAO QY, CROOM-CARTER DS, TIERNEY RJ, et al. Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort. J Virol 1998: 72: 4352-4363.
26. SITKI-GREEN D, COVINGTON M, RAABTRAUB N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 2003: 77: 1840-1847.
27. YAO QY, ROWE M, MARTIN B, YOUNG LS, RICKINSON AB. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 1991: 72: 1579-1590.